Notice of AGM and 2023 Report and Accounts

Intelligent Ultrasound Group PLC

23 May 2024

 

Intelligent Ultrasound Group plc

(the "Group" or the "Company")

Notice of Annual General Meeting and

2023 Report and Accounts

Intelligent Ultrasound Group plc (AIM: IUG), the 'classroom to clinic' ultrasound company, specialising in artificial intelligence (AI) software and simulation, announces that the following documents have been posted or otherwise been made available to shareholders:

·      2023 Report and Accounts; and

·      Notice of 2024 Annual General Meeting ("AGM")

The Notice of AGM and the 2023 Report and Accounts are also available to view on the Company's website at: www.intelligentultrasound.com/reports-presentations

The AGM will be held on Tuesday 18 June 2024 at 10.30 a.m. at Cavendish Capital Markets Limited, One Bartholemew Close, London EC1A 7BL.

Details of how to participate in the Meeting and the resolutions that will be tabled for shareholder approval are set out in the Notice of AGM.

For further information, please contact:

Intelligent Ultrasound Group plc	www. intelligentultrasound.com
Stuart Gall, CEO	Tel: [phone]
Helen Jones, CFO
Cavendish Capital Markets Limited (Nominated Advisor and Broker)	Tel:  [phone]
Giles Balleny/Dan Hodkinson (Corporate Finance)
Nigel Birks (ECM) Ondraya Swanson (ECM) Dale Bellis (Sales)
TB Cardew - PR Advisers Allison Connolly Emma Pascoe-Watson Jessica Pilling	[e-mail] Tel: [phone] Tel: [phone] Tel: [phone]

About Intelligent Ultrasound Group

Intelligent Ultrasound (AIM: IUG) is one of the world's leading 'classroom to clinic' ultrasound companies, specialising in real-time hi-fidelity virtual reality simulation for the ultrasound training market ('classroom') and artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market ('clinic'). Based in Cardiff in the UK and Atlanta in the US, the Group has two revenue streams:

Simulation

Real-time hi-fidelity ultrasound education and training through simulation. Our main products are the ScanTrainer obstetrics and gynaecology training simulator, the HeartWorks echocardiography training simulator, the BodyWorks Eve Point of Care and Emergency Medicine training simulator and the BabyWorks Neonate and Paediatric training simulator. To date over 1,700 simulators have been sold to over 800 medical institutions around the world.

Clinical AI software

Deep learning-based algorithms to make ultrasound machines smarter and more accessible using our proprietary ScanNav ultrasound image analysis technology. Current products on the market utilising this technology are GE HealthCare's SonoLyst software that is incorporated in their Voluson Expert, Signature and SWIFT ultrasound machines; ScanNav Anatomy PNB that simplifies ultrasound-guided needling by providing the user with real-time AI-based anatomy highlighting for a range of medical procedures; and NeedleTrainer that teaches real-time ultrasound-guided needling and incorporates ScanNav Anatomy PNB. 

www.intelligentultrasound.com

NOTE: ScanNav Anatomy PNB is CE approved and cleared for sale in the US by the FDA but is not available for sale in any other territory requiring government approval for this type of product.

 

END